MX2007011826A - Composiciones farmaceuticas de liberacion controlada de liotironina y metodos para elaborar y utilizar las mismas. - Google Patents

Composiciones farmaceuticas de liberacion controlada de liotironina y metodos para elaborar y utilizar las mismas.

Info

Publication number
MX2007011826A
MX2007011826A MX2007011826A MX2007011826A MX2007011826A MX 2007011826 A MX2007011826 A MX 2007011826A MX 2007011826 A MX2007011826 A MX 2007011826A MX 2007011826 A MX2007011826 A MX 2007011826A MX 2007011826 A MX2007011826 A MX 2007011826A
Authority
MX
Mexico
Prior art keywords
methods
pharmaceutical compositions
liothyronine
making
same
Prior art date
Application number
MX2007011826A
Other languages
English (en)
Inventor
Kevin H Sills
David P Hause
Martin Wade Beasley
Irwin Klein
Charles L Pamplin
David John Reynolds
Original Assignee
King Pharmaceuticals Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Res & Dev filed Critical King Pharmaceuticals Res & Dev
Publication of MX2007011826A publication Critical patent/MX2007011826A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Esta invencion se relaciona a composiciones farmaceuticas de liberacion sostenida que comprenden liotironina, o una sal o derivado de la misma. Adicionalmente, la presente invencion se dirige a metodos de fabricacion y metodos para utilizar las composiciones farmaceuticas de la presente invencion.
MX2007011826A 2005-03-31 2006-03-31 Composiciones farmaceuticas de liberacion controlada de liotironina y metodos para elaborar y utilizar las mismas. MX2007011826A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66662105P 2005-03-31 2005-03-31
PCT/US2006/012272 WO2006105482A2 (en) 2005-03-31 2006-03-31 Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same

Publications (1)

Publication Number Publication Date
MX2007011826A true MX2007011826A (es) 2007-11-22

Family

ID=37054215

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007011826A MX2007011826A (es) 2005-03-31 2006-03-31 Composiciones farmaceuticas de liberacion controlada de liotironina y metodos para elaborar y utilizar las mismas.

Country Status (11)

Country Link
US (1) US20060246133A1 (es)
EP (1) EP1863446A2 (es)
JP (1) JP2008534621A (es)
KR (1) KR20070119714A (es)
CN (1) CN101175477A (es)
AU (1) AU2006230557A1 (es)
BR (1) BRPI0609779A2 (es)
CA (1) CA2603313A1 (es)
IL (1) IL185723A0 (es)
MX (1) MX2007011826A (es)
WO (1) WO2006105482A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525461D0 (en) * 2005-12-15 2006-01-25 Archimedes Dev Ltd Pharmaceutical compositions
WO2008057464A2 (en) * 2006-11-01 2008-05-15 King Pharmaceuticals Research And Development, Inc. Compositions and methods for improving the bioavailability of liothyronine
ES2384941T3 (es) * 2007-02-16 2012-07-16 Csem Centre Suisse D'electronique Et De Microtechnique Sa - Recherche Et Developpement Método de verificación
ITMI20112066A1 (it) * 2011-11-14 2013-05-15 Altergon Sa Preparazione farmaceutica orale monodose di ormoni tiroidei t3 e t4
WO2017192458A1 (en) * 2016-05-03 2017-11-09 Spectrix Therapeutics, LLC Compositions and methods of providing thyroid hormone or analogs thereof
US10695309B2 (en) * 2017-03-31 2020-06-30 Western New England University Sustained-release liothyronine formulations, method of preparation and method of use thereof
US11964048B2 (en) * 2020-12-18 2024-04-23 Amneal Complex Products Research Llc Sustained release compositions comprising liothyronine
CN115645361B (zh) * 2022-09-30 2023-11-21 天津市眼科医院 一种用于加强角膜生物力学性质的眼用制剂及t3的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200193A (en) * 1987-04-22 1993-04-06 Mcneilab, Inc. Pharmaceutical sustained release matrix and process
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
DK0550108T3 (da) * 1991-12-30 1999-01-04 Akzo Nobel Nv Thyreoaktiv sammensætning med langvarig frigivelse
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6555581B1 (en) * 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods

Also Published As

Publication number Publication date
WO2006105482A2 (en) 2006-10-05
JP2008534621A (ja) 2008-08-28
CA2603313A1 (en) 2006-10-05
AU2006230557A1 (en) 2006-10-05
EP1863446A2 (en) 2007-12-12
US20060246133A1 (en) 2006-11-02
WO2006105482A3 (en) 2006-12-07
IL185723A0 (en) 2008-01-06
BRPI0609779A2 (pt) 2011-10-18
KR20070119714A (ko) 2007-12-20
CN101175477A (zh) 2008-05-07

Similar Documents

Publication Publication Date Title
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
WO2006136357A3 (de) Kristalline modifikationen des pyraclostrobins
UA97502C2 (ru) Кристаллическая твердая основа разагилина
TW200716646A (en) (S)-N-methylnaltrexone
UY30578A1 (es) Nuevos derivados de 2,4??- y 3, 4??-bipiridina sustituidos, procedimientos para su preparacion, medicamentos conteniéndolos y aplicaciones
CY1110209T1 (el) Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα
TW200621313A (en) Pharmaceutical compositions
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
UA92894C2 (ru) Способ приготовления и применения композиции адсорбента фосфата, адсорбент фосфата, композиция адсорбента фосфата
RS54217B1 (en) SOME TRIAZOLOPIRAZINS, THEIR COMPOSITIONS AND THE METHODS OF USING THEM
MX2007011826A (es) Composiciones farmaceuticas de liberacion controlada de liotironina y metodos para elaborar y utilizar las mismas.
NO20090175L (no) Stabile laquinimod sammensetninger
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
IL195341A0 (en) Methods and materials for making simvastatin and related compounds
TW200634023A (en) Amide prodrug of gemcitabine, compositions and use thereof
EA200601608A1 (ru) Способ производства твёрдой фармацевтической композиции
TW200732410A (en) Sprayable acoustic compositions
WO2007025146A3 (en) Balsalazide formulations and manufacture and use thereof
EA200970126A1 (ru) Способ получения прегабалина и его энантиомера
TW200728310A (en) Process for the preparation of ferri-succinylcasein
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200738713A (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
MX2009000768A (es) Lactamas macrociclicas.
TW200621260A (en) Selected fused heterocyclics and uses thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal